WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |

Search International and National Patent Collections
World Intellectual Property Organization
PATENTSCOPE will be unavailable a few hours for maintenance reason on Saturday 18.08.2018 at 9:00 AM CEST
Machine translation
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2005/016132 International Application No.: PCT/US2004/003307
Publication Date: 24.02.2005 International Filing Date: 04.02.2004
C12Q 1/70 (2006.01) ,C12N 15/50 (2006.01) ,A61K 39/215 (2006.01) ,C07K 16/10 (2006.01)
Applicants: KWANG, Jimmy[US/SG]; SG (UsOnly)
LING, Ai, Ee,[SG/SG]; SG (UsOnly)
OOI, Eng, Eong[SG/SG]; SG (UsOnly)
CHNG, Hiok, Hee[SG/SG]; SG (UsOnly)
TEMASEK LIFE SCIENCES LABORATORY LIMITED[SG/SG]; 1 Research Link The National University of Singapore Singapore 117604, SG (AllExceptUS)
Inventors: KWANG, Jimmy; SG
LING, Ai, Ee,; SG
OOI, Eng, Eong; SG
CHNG, Hiok, Hee; SG
Agent: ERNST, Barbara, G. ; Rothwell, Figg, Ernst & Manbeck, P.C. 1425 K Street, N.W. Suite 800 Washington, DC 20005, US
Priority Data:
Abstract: front page image
(EN) This invention relates to Severe Acute Respiratory Syndrome associated coronavirus (SARS virus) isolated and recombinant proteins, in particular the nucleocapsid (N) protein and spike (S) protein, as well as fragments thereof and their use in the diagnosis, treatment and prevention of Severe Acute Respiratory Syndrome (SARS). The proteins and fragments carry epitopes that are specific for the SARS virus. Thus, detection methods based on these proteins or fragments as well as the monoclonal antibodies against these proteins or fragments are specific for the SARS virus.
(FR) La présente invention concerne les protéines isolées et recombinantes du coronavirus associé au Syndrome Respiratoire Aigu Sévère (virus du SRAS), en particulier la protéine du nucléocapside (N) et la protéine des spicules (S), ainsi que certains de leurs fragments et leur utilisation pour le diagnostic, le traitement et la prévention du Syndrome Respiratoire Aigu Sévère (SRAS). Ces protéines et fragments portent des épitopes qui sont spécifiques du virus du SRAS. Cela fait que les procédés de détection reposant sur ces protéines ou fragments, ainsi que les anticorps monoclonaux dirigés contre ces protéines ou fragments, sont spécifiques du virus du SRAS.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)